-+ 0.00%
-+ 0.00%
-+ 0.00%

RETENSION PHARMACEUTICALS INC. : LEERINK PARTNERS INITIATES COVERAGE WITH OUTPERFORM RATING; PRICE TARGET $50

Reuters·11/03/2026 11:33:31

Please log in to view news